• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吡拉西坦治疗慢性支气管炎合并动脉粥样硬化患者的疗效

[The efficacy of piracetam in treating patients with chronic bronchitis and concomitant atherosclerosis].

作者信息

Nikitin A V, Chesnokova I V, Sysoeva L I

出版信息

Vrach Delo. 1990 Nov(11):17-8.

PMID:2098971
Abstract

The nootropic agent pyracetam was used in patients suffering of chronic bronchitis associated with concomitant atherosclerosis. Pyracetam was administered intravenously in saline solutions. It was found that the group of patients receiving pyracetam revealed earlier normalization of clinico-laboratory indices. Pyracetam also produced immunocorrective and antioxidant effect resulting in normalization immunity values and activity of lipid peroxidation.

摘要

促智药吡拉西坦用于患有慢性支气管炎并伴有动脉粥样硬化的患者。吡拉西坦以生理盐水静脉给药。结果发现,接受吡拉西坦治疗的患者组临床实验室指标更早恢复正常。吡拉西坦还产生免疫纠正和抗氧化作用,使免疫值和脂质过氧化活性恢复正常。

相似文献

1
[The efficacy of piracetam in treating patients with chronic bronchitis and concomitant atherosclerosis].吡拉西坦治疗慢性支气管炎合并动脉粥样硬化患者的疗效
Vrach Delo. 1990 Nov(11):17-8.
2
[Immunological and metabolic disorders and the means for their correction in patients with chronic bronchitis].[慢性支气管炎患者的免疫和代谢紊乱及其纠正方法]
Ter Arkh. 1991;63(12):7-11.
3
[Correction of metabolic and immunologic disorders in chronic bronchitis with piracetam].[用吡拉西坦纠正慢性支气管炎中的代谢和免疫紊乱]
Sov Med. 1990(3):70-2.
4
[The efficacy of membrane-stabilizing therapy in patients with chronic obstructive bronchitis].[膜稳定疗法对慢性阻塞性支气管炎患者的疗效]
Ter Arkh. 1997;69(10):34-6.
5
[Effects of essential oil on lipid peroxidation and lipid metabolism in patients with chronic bronchitis].
Klin Med (Mosk). 1997;75(10):43-5.
6
[A clinico-epidemiological study on the efficacy of thymopentin therapy in patients with chronic bronchitis and cellular immunity deficiency].胸腺五肽治疗慢性支气管炎合并细胞免疫缺陷患者疗效的临床流行病学研究
Recenti Prog Med. 1990 Jan;81(1):29-32.
7
[The activity of lipid peroxidation and proteolysis in assessing the stability of the course and the prognosis of ischemic heart disease in patients with chronic bronchitis].[脂质过氧化和蛋白水解活性在评估慢性支气管炎患者缺血性心脏病病程稳定性及预后中的作用]
Ter Arkh. 1992;64(3):41-4.
8
[The clinico-immunological efficacy of the likopid treatment of chronic bronchitis patients].[力如沛治疗慢性支气管炎患者的临床免疫疗效]
Ter Arkh. 1998;70(3):38-40.
9
[The clinical instrumental evaluation of treatment efficacy in patients with concomitant atherosclerosis of the coronary, cerebral and peripheral arteries].
Ter Arkh. 1991;63(4):90-3.
10
[Effect of levamisole on cellular immunity indices in chronic bronchitis and chronic pneumonia patients].
Ter Arkh. 1984;56(10):29-31.